Recent findings suggest that post-COVID chronic cough may be driven by neurological factors, not just respiratory issues.
The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback